New Delhi: Synokem Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under the Central Drug ...

With Doctor Who allegedly about to be exterminated by the BBC and Disney over its declining viewership, is there any explanation for its downfall beyond condemning "woke story lines"?

Amezosvatein has shown excellent immunogenicity and improved tolerability in Phase 2 study -- Medicxi leads round, joined by ...

Akyea, the Akufo-Addo-fired former Minister for Works, Housing and Water Resources, would rather heartily commend the ...

CALR mutations occur in about 20% of patients with primary and post-essential thrombocythemia myelofibrosis, as per the study ...

We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going to take a look at where Dr.

The myelofibrosis drug landscape has become more crowded since Syntara decided to focus on the disease in 2020, but the ...

While the myelofibrosis drug landscape has become more crowded since Syntara (then Pharmaxis) decided to focus on that ...

Povorcitinib is an oral Janus kinase 1 selective inhibitor that works to reduce the overactive inflammatory signaling pathway seen in HS.

Scientists warn that Trump’s cuts to US medical research could slow life-saving treatments, delaying breakthroughs in cancer, ...

The super-skinny Janus base nanoparticles Chen's lab is working on are different ... focuses on translating this technology into a product available on the market, and Dr. Lorenzo Deveza from Baylor ...

Newly released data from the phase 3 STOP-HS clinical trial program reveal positive results in hidradenitis suppurativa from ...